Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
VoxCell BioInnovationvoxcell.comVoxCell provides 3D bioprinted, vascularized human tissue models for preclinical drug development, using living cells and multicellular components to create complex, highly reproducible tissues. These models feature functional vascular networks with endothelial linings and physiologic flow that mimic in-vivo microenvironments, enabling predictive ADME, drug delivery, distribution, and long-term toxicity studies. Positioning itself as an alternative to animal testing, VoxCell aligns with NAMs and microphysiological systems and offers bioprinting technology, bioinks, and vascularization software to accelerate pharmaceutical pipelines through partnerships.
Parse Score
